nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—nervous system—Gilles de la Tourette syndrome	0.0538	0.116	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—Gilles de la Tourette syndrome	0.0518	0.111	CbGeAlD
Isoprenaline—PIK3R2—brain—Gilles de la Tourette syndrome	0.0411	0.0884	CbGeAlD
Isoprenaline—PIK3R1—midbrain—Gilles de la Tourette syndrome	0.0379	0.0815	CbGeAlD
Isoprenaline—PIK3R3—nervous system—Gilles de la Tourette syndrome	0.0365	0.0785	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—Gilles de la Tourette syndrome	0.0351	0.0755	CbGeAlD
Isoprenaline—PIK3R3—brain—Gilles de la Tourette syndrome	0.0279	0.06	CbGeAlD
Isoprenaline—PIK3R1—brain—Gilles de la Tourette syndrome	0.0238	0.0512	CbGeAlD
Isoprenaline—ADRBK1—nervous system—Gilles de la Tourette syndrome	0.0216	0.0464	CbGeAlD
Isoprenaline—MAPK1—nervous system—Gilles de la Tourette syndrome	0.0213	0.0457	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—Gilles de la Tourette syndrome	0.0208	0.0446	CbGeAlD
Isoprenaline—MAPK1—central nervous system—Gilles de la Tourette syndrome	0.0205	0.044	CbGeAlD
Isoprenaline—ADRB3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0165	0.0334	CbGpPWpGaD
Isoprenaline—ADRBK1—brain—Gilles de la Tourette syndrome	0.0165	0.0354	CbGeAlD
Isoprenaline—MAPK1—brain—Gilles de la Tourette syndrome	0.0162	0.0349	CbGeAlD
Isoprenaline—ADRB3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0141	0.0285	CbGpPWpGaD
Isoprenaline—ADRB3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0137	0.0277	CbGpPWpGaD
Isoprenaline—ADRB3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0127	0.0258	CbGpPWpGaD
Isoprenaline—ADRB3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0118	0.024	CbGpPWpGaD
Isoprenaline—ADRB3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0115	0.0233	CbGpPWpGaD
Isoprenaline—ADRB3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0107	0.0217	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00981	0.0198	CbGpPWpGaD
Isoprenaline—MAPK1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00976	0.0197	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00959	0.0194	CbGpPWpGaD
Isoprenaline—MAPK1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00928	0.0188	CbGpPWpGaD
Isoprenaline—MAPK1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0091	0.0184	CbGpPWpGaD
Isoprenaline—ADRB1—nervous system—Gilles de la Tourette syndrome	0.00902	0.0194	CbGeAlD
Isoprenaline—ADRB3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00892	0.0181	CbGpPWpGaD
Isoprenaline—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.00869	0.0187	CbGeAlD
Isoprenaline—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00836	0.0169	CbGpPWpGaD
Isoprenaline—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00818	0.0165	CbGpPWpGaD
Isoprenaline—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00812	0.0164	CbGpPWpGaD
Isoprenaline—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00794	0.0161	CbGpPWpGaD
Isoprenaline—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00756	0.0153	CbGpPWpGaD
Isoprenaline—ADRB3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0075	0.0152	CbGpPWpGaD
Isoprenaline—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0074	0.015	CbGpPWpGaD
Isoprenaline—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00703	0.0142	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling events mediated by TCPTP—MET—Gilles de la Tourette syndrome	0.00699	0.0141	CbGpPWpGaD
Isoprenaline—ADRB1—brain—Gilles de la Tourette syndrome	0.0069	0.0148	CbGeAlD
Isoprenaline—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00688	0.0139	CbGpPWpGaD
Isoprenaline—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00682	0.0138	CbGpPWpGaD
Isoprenaline—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00668	0.0135	CbGpPWpGaD
Isoprenaline—L-DOPA—DRD4—Gilles de la Tourette syndrome	0.00665	0.164	CrCbGaD
Isoprenaline—PIK3R1—a6b1 and a6b4 Integrin signaling—MET—Gilles de la Tourette syndrome	0.00636	0.0129	CbGpPWpGaD
Isoprenaline—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00636	0.0129	CbGpPWpGaD
Isoprenaline—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00622	0.0126	CbGpPWpGaD
Isoprenaline—Dopamine—DRD4—Gilles de la Tourette syndrome	0.00618	0.153	CrCbGaD
Isoprenaline—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.00582	0.0125	CbGeAlD
Isoprenaline—L-DOPA—DRD3—Gilles de la Tourette syndrome	0.00573	0.142	CrCbGaD
Isoprenaline—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.0056	0.012	CbGeAlD
Isoprenaline—PIK3R1—FGF signaling pathway—MET—Gilles de la Tourette syndrome	0.0055	0.0111	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling of Hepatocyte Growth Factor Receptor—MET—Gilles de la Tourette syndrome	0.00541	0.0109	CbGpPWpGaD
Isoprenaline—Dopamine—DRD3—Gilles de la Tourette syndrome	0.00533	0.132	CrCbGaD
Isoprenaline—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0053	0.0107	CbGpPWpGaD
Isoprenaline—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00518	0.0105	CbGpPWpGaD
Isoprenaline—Dopamine—SLC6A3—Gilles de la Tourette syndrome	0.00496	0.123	CrCbGaD
Isoprenaline—MAPK1—Syndecan-1-mediated signaling events—MET—Gilles de la Tourette syndrome	0.00495	0.01	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00486	0.00982	CbGpPWpGaD
Isoprenaline—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00445	0.00901	CbGpPWpGaD
Isoprenaline—CYP1A1—brain—Gilles de la Tourette syndrome	0.00445	0.00956	CbGeAlD
Isoprenaline—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.00441	0.00891	CbGpPWpGaD
Isoprenaline—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00436	0.00881	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MET—Gilles de la Tourette syndrome	0.00401	0.00812	CbGpPWpGaD
Isoprenaline—L-DOPA—DRD2—Gilles de la Tourette syndrome	0.00397	0.098	CrCbGaD
Isoprenaline—Norepinephrine—DRD2—Gilles de la Tourette syndrome	0.00397	0.098	CrCbGaD
Isoprenaline—PIK3R1—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00393	0.00796	CbGpPWpGaD
Isoprenaline—MAPK1—FGF signaling pathway—MET—Gilles de la Tourette syndrome	0.00374	0.00756	CbGpPWpGaD
Isoprenaline—Dopamine—DRD2—Gilles de la Tourette syndrome	0.00369	0.0911	CrCbGaD
Isoprenaline—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00363	0.00735	CbGpPWpGaD
Isoprenaline—PIK3R3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00353	0.00715	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00353	0.00714	CbGpPWpGaD
Isoprenaline—PIK3R2—TGF-beta Signaling Pathway—MET—Gilles de la Tourette syndrome	0.00332	0.00671	CbGpPWpGaD
Isoprenaline—PIK3R3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00316	0.00639	CbGpPWpGaD
Isoprenaline—PIK3R2—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00282	0.0057	CbGpPWpGaD
Isoprenaline—ADRBK1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00278	0.00561	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MET—Gilles de la Tourette syndrome	0.00273	0.00552	CbGpPWpGaD
Isoprenaline—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00272	0.0055	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—HDC—Gilles de la Tourette syndrome	0.0027	0.00546	CbGpPWpGaD
Isoprenaline—PIK3R1—TGF-beta Signaling Pathway—MET—Gilles de la Tourette syndrome	0.00269	0.00544	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00267	0.00541	CbGpPWpGaD
Isoprenaline—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00264	0.00534	CbGpPWpGaD
Isoprenaline—PIK3R2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00252	0.0051	CbGpPWpGaD
Isoprenaline—ADRBK1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00248	0.00502	CbGpPWpGaD
Isoprenaline—PIK3R2—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.00248	0.00501	CbGpPWpGaD
Isoprenaline—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00246	0.00497	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00233	0.00471	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0023	0.00466	CbGpPWpGaD
Isoprenaline—PIK3R1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00228	0.00462	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00226	0.00457	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00215	0.00435	CbGpPWpGaD
Isoprenaline—MAPK1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00214	0.00432	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00211	0.00426	CbGpPWpGaD
Isoprenaline—PIK3R1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00204	0.00413	CbGpPWpGaD
Isoprenaline—PIK3R1—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.00201	0.00406	CbGpPWpGaD
Isoprenaline—MAPK1—TGF-beta Signaling Pathway—MET—Gilles de la Tourette syndrome	0.00183	0.0037	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00177	0.00359	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00174	0.00353	CbGpPWpGaD
Isoprenaline—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00172	0.00348	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00172	0.00348	CbGpPWpGaD
Isoprenaline—MAPK1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00164	0.00331	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00161	0.00326	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0016	0.00325	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00159	0.00322	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00158	0.00319	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00157	0.00317	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00154	0.00312	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00153	0.0031	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00148	0.00298	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00146	0.00295	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00144	0.00292	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00144	0.00291	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00143	0.00289	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0014	0.00284	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00139	0.00281	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00138	0.0028	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.00137	0.00276	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00135	0.00274	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00134	0.00272	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00131	0.00266	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00131	0.00264	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00127	0.00256	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00125	0.00253	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00125	0.00253	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00123	0.00249	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00122	0.00247	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00121	0.00245	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00115	0.00233	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00115	0.00232	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00113	0.00229	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00113	0.00228	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00112	0.00227	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00112	0.00226	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0011	0.00223	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00105	0.00213	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00104	0.00211	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00103	0.00208	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00103	0.00208	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00103	0.00207	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00207	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00102	0.00207	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00204	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.001	0.00203	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.001	0.00202	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.001	0.00202	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000997	0.00202	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000973	0.00197	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000952	0.00193	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000933	0.00189	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000931	0.00188	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000929	0.00188	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000915	0.00185	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00091	0.00184	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000907	0.00183	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000905	0.00183	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000891	0.0018	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000884	0.00179	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000876	0.00177	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000857	0.00173	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000853	0.00173	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000844	0.00171	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000828	0.00168	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000823	0.00167	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000803	0.00162	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000791	0.0016	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000772	0.00156	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000729	0.00147	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000718	0.00145	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00068	0.00138	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00067	0.00135	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000667	0.00135	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00066	0.00134	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000657	0.00133	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000652	0.00132	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000651	0.00132	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00065	0.00132	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000636	0.00129	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000635	0.00128	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000634	0.00128	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000616	0.00124	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000615	0.00124	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000606	0.00123	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000595	0.0012	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000591	0.00119	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000582	0.00118	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000578	0.00117	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000577	0.00117	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000573	0.00116	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000565	0.00114	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000551	0.00111	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00054	0.00109	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00054	0.00109	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000538	0.00109	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000538	0.00109	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000535	0.00108	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000529	0.00107	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000526	0.00106	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000525	0.00106	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000522	0.00106	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000513	0.00104	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000498	0.00101	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000489	0.000988	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000486	0.000984	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000478	0.000967	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000431	0.000871	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000424	0.000858	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000402	0.000812	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000377	0.000762	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000375	0.000758	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000369	0.000746	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000364	0.000735	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000349	0.000706	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000342	0.000692	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000341	0.000689	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000339	0.000685	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000335	0.000677	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000319	0.000646	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000312	0.000632	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00031	0.000627	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000303	0.000613	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000289	0.000584	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000282	0.000571	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000237	0.00048	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000202	0.000409	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000198	0.0004	CbGpPWpGaD
